The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein
Abstract
We have studied synaptic function in a transgenic mouse strain relevant to Alzheimer's disease (AD), overexpressing the 695 amino acid isoform of human amyloid precursor protein with K670N and M671L mutations (APP 695 SWE mice), which is associated with early-onset familial AD. Aged-transgenic mice had substantially elevated levels of Aβ (up to 22 μmol/gm) and displayed characteristic Aβ plaques. Hippocampal slices from 12-month-old APP 695 SWE transgenic animals displayed reduced levels of synaptic transmission in the CA1 region when compared with wild-type littermate controls. Inclusion of the ionotropic glutamate receptor antagonist kynurenate during preparation of brain slices abolished this deficit. At 18 months of age, a selective deficit in basal synaptic transmission was observed in the CA1 region despite treatment with kynurenate. Paired-pulse facilitation and long-term potentiation (LTP) were normal in APP 695 SWE transgenic mice at both 12 and 18 months of age. Thus, although aged APP 695 SWE transgenic mice have greatly elevated levels of Aβ protein, increased numbers of plaques, and reduced basal synaptic transmission, LTP can still be induced and expressed normally. We conclude that increased susceptibility to excitotoxicity rather than a specific effect on LTP is the primary cause of cognitive deficits in APP 695 SWE mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Posttetanic potentiation and long-term potentiation in the CA1 area were apparently normal in Tg2576 hippocampal slices at both ages.
“Note that posttetanic potentiation and LTP in the CA1 area were apparently normal in Tg2576 hippocampal slices at both ages, which is in agreement with previous reports that LTP was not impaired until at the age of >12 mo old (Chapman et al., 1999; Fitzjohn et al., 2001).”
From VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology (2011) · cites this paper as Fitzjohn et al., 2001
The CA1 synaptic-plasticity results (page unavailable) report normal LTP in transgenic slices at both 12 and 18 months. The paper does not report posttetanic potentiation; it measures paired-pulse facilitation instead. Its finding of normal LTP at 18 months also does not support the sentence’s implication that LTP becomes impaired after 12 months. (LLM, conf=0.87)
Experimental — accuracy not yet measuredIn the Schaffer collateral pathway (SC-CA1), the deficiency was not detectable until 12-18 months old.
“In the Schaffer collateral (SC) pathway (SC-CA1), the deficiency was not detectable until 12–18 mo old (Chapman et al., 1999; Fitzjohn et al., 2001).”
From VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology (2011) · cites this paper as Fitzjohn et al., 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649
Zhang, F., Eckman, C., Younkin, S., Hsiao, K. K., & Iadecola, C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-20-07655.1997 · Cited by 205
Flagged first, then by citations
Research works printed but not linked: 35
- Anderson, 1997, A data acquisition program for on-line analysis of long-term potentiation and long-term depression., Soc Neurosci Abstr, 23, 665
- 10.1016/S0896-6273(00)80230-5 · DOI · Paper page
- Chapman, 1997, Abnormal synaptic transmission in aged APP transgenic mice., J Physiol (Lond), 501, 95.P
- 10.1038/6374 · DOI · Paper page
- 10.1523/JNEUROSCI.10-08-02493.1990 · DOI
- 10.1042/bst0180390 · DOI
- 10.1016/S0306-4522(98)00410-2 · DOI
- 10.1016/S0304-3940(00)01204-0 · DOI
- Frautschy, 1998, Microglial response to amyloid plaques in APPSW transgenic mice., Am J Pathol, 152, 307
- 10.1002/(SICI)1098-1063(1999)9:3<201::AID-HIPO1>3.0.CO;2-P · DOI
- 10.1016/S0006-8993(00)02615-9 · DOI
- 10.1016/S0166-2236(96)01030-2 · DOI · Paper page
- Hsiao, 1995, Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins., Neuron, 25, 1203, 10.1016/0896-6273(95)90107-8 · DOI
- 10.1126/science.274.5284.99 · DOI · Paper page
- 10.1096/fj.14.11.1508 · DOI
- 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W · DOI
- Kuenzi, 1999, The rd mutation in cGMP PDE-IV does not affect synaptic plasticity in mouse hippocampus., Soc Neurosci Abstr, 25, 398.9
- 10.1016/S0006-8993(99)01698-4 · DOI
- 10.1097/00005072-199708000-00008 · DOI · Paper page
- 10.1016/0166-2236(94)90008-6 · DOI
- 10.1016/0896-6273(93)90315-I · DOI · Paper page
- 10.1523/JNEUROSCI.20-04-01358.2000 · DOI
- 10.1212/WNL.34.7.939 · DOI · Paper page
- 10.1074/jbc.274.10.6483 · DOI · Paper page
- Morton, 1999, Selective disruption of late-phase LTP in mice under-expressing presenilin-1., Soc Neurosci Abstr, 25, 398.10
- 10.1038/387500a0 · DOI
- 10.1016/S0166-2236(97)01168-5 · DOI
- 10.1006/nbdi.1998.0207 · DOI
- 10.1146/annurev.neuro.21.1.479 · DOI
- Seabrook, 1999, Transgenic animals relevant to Alzheimer's disease., Neuropharmacology, 38, 1, 10.1016/S0028-3908(98)00170-1 · DOI
- 10.1016/S0028-3908(98)00204-4 · DOI
- 10.1016/S0896-6273(00)00125-2 · DOI
- Wimer, 1991, The mouse gene retinal degeneration (rd) may reduce the number of neurons present in the adult hippocampal dentate gyrus., Brain Res, 547, 275, 10.1016/0006-8993(91)90971-W · DOI
- 10.1016/S0306-4522(97)00053-5 · DOI
- 10.1006/nbdi.1999.0271 · DOI
Cited by
Sorted by citations
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Self-citationAlzheimer's disease: Targeting the Cholinergic System
H. Ferreira-Vieira, T., M. Guimaraes, I., R. Silva, F., & M. Ribeiro, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150716165726 · Cited by 1,551
Synaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517
Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
Cissé, M., Halabisky, B., Harris, J., Devidze, N., Dubal, D. B., Sun, B., Orr, A., Lotz, G., Kim, D. H., Hamto, P., et al. (2011) · Nature · doi:10.1038/nature09635 · Cited by 433
Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
Gimbel, D. A., Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., & Strittmatter, S. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0395-10.2010 · Cited by 418
Kimura, R., & Ohno, M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.006 · Cited by 333
VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology
Wen, L., Tang, F.-L., Hong, Y., Luo, S.-W., Wang, C.-L., He, W., Shen, C., Jung, J.-U., Xiong, F., Lee, D.-H., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201105109 · Cited by 270
Dickey, C. A., Loring, J. F., Montgomery, J., Gordon, M. N., Eastman, P. S., & Morgan, D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05219.2003 · Cited by 242
Ravassard, P., Pachoud, B., Comte, J.-C., Mejia-Perez, C., Scoté-Blachon, C., Gay, N., Claustrat, B., Touret, M., Luppi, P.-H., & Salin, P. A. (2009) · Sleep · doi:10.1093/sleep/32.2.227 · Cited by 177
Saura, C. A., Chen, G., Malkani, S., Choi, S.-Y., Takahashi, R. H., Zhang, D., Gouras, G. K., Kirkwood, A., Morris, R. G. M., & Shen, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1247-05.2005 · Cited by 157
Harris, J. A., Devidze, N., Halabisky, B., Lo, I., Thwin, M. T., Yu, G.-Q., Bredesen, D. E., Masliah, E., & Mucke, L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5341-09.2010 · Cited by 146
Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ
Zhao, W.-Q., Lacor, P. N., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011015 · Cited by 154
Hinrich, A. J., Jodelka, F. M., Chang, J. L., Brutman, D., Bruno, A. M., Briggs, C. A., James, B. D., Stutzmann, G. E., Bennett, D. A., Miller, S. A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505846 · Cited by 127
King, D. L., & Arendash, G. W. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03294-2 · Cited by 105
APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy
Breyhan, H., Wirths, O., Duan, K., Marcello, A., Rettig, J., & Bayer, T. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0539-7 · Cited by 87
Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
McDaid, J., Mustaly-Kalimi, S., & Stutzmann, G. E. (2020) · Cells · doi:10.3390/cells9122655 · Cited by 73
Vlkolinský, R., Siggins, G. R., Campbell, I. L., & Krucker, T. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.011 · Cited by 57
β-Amyloid Enhances Glial Glutamate Uptake Activity and Attenuates Synaptic Efficacy
Ikegaya, Y., Matsuura, S., Ueno, S., Baba, A., Yamada, M. K., Nishiyama, N., & Matsuki, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203764200 · Cited by 39
Metadata
- Authors
- Fitzjohn, S. M., Morton, R. A., Kuenzi, F., Rosahl, T. W., Shearman, M., Lewis, H., Smith, D., Reynolds, D. S., Davies, C. H., Collingridge, G. L., & Seabrook, G. R.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2001-07-01
- Volume
- 21
- Issue
- 13
- Pages
- 4691-4698
- ISSN
- 0270-6474
- 1529-2401
- Cited by
- 168
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review